Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Kusuma Kumari Garikapati"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-20 (2023)
Abstract The present study hypothesises that the selective brain β2 receptor activation through β2-adrenoreceptor agonist (β2ARA), Formoterol (FMT), suppresses SNCA gene expression, a pathological hallmark of Parkinson’s disease (PD) in brain. F
Externí odkaz:
https://doaj.org/article/bcc67ac13c084193bb46b3c6b1fac74b
Autor:
Ravi Kiran, Ammu V. V. V.1 (AUTHOR), Kusuma Kumari, Garikapati1 (AUTHOR), Krishnamurthy, Praveen T.1 (AUTHOR) praveentk@jssuni.edu.in, Kalyan Chekreverthy, Bhadram2 (AUTHOR)
Publikováno v:
Advanced Pharmaceutical Bulletin. 2024, Vol. 14 Issue 2, p253-254. 2p.
Autor:
Ravi Kiran, Ammu V.V.V.1 (AUTHOR), Kusuma Kumari, Garikapati1 (AUTHOR), Krishnamurthy, Praveen T.1 (AUTHOR) praveentk7812@gmail.com
Publikováno v:
Advanced Pharmaceutical Bulletin. 2024, Vol. 14 Issue 1, p5-6. 2p.
Autor:
Kusuma Kumari Garikapati, Ravi Kiran Ammu V. V. V., Praveen Thaggikuppe Krishnamurthy, Narenderan S. T., Babu B., Krishnaveni Nagappan
Publikováno v:
Biomedical chromatography : BMCREFERENCES. 36(5)
A bioanalytical method for the quantification of rosiglitazone in rat plasma and tissues (adipose tissue, heart, brain, bone, and kidney) using LC-MS/MS was developed and validated. Chromatographic separation was achieved on a Gemini C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0abb443598b3580a1cb8f3290089e6b3
https://pubmed.ncbi.nlm.nih.gov/34993979
https://pubmed.ncbi.nlm.nih.gov/34993979
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Piyong, Sola, Praveen Thaggikuppe, Krishnamurthy, Mamta, Kumari, Gowramma, Byran, Hosahalli Veerabhadrappa, Gangadharappa, Kusuma Kumari, Garikapati
Publikováno v:
Neurochemistry International. 158:105380
One of the most significant threats in Parkinson's disease (PD) is neurodegeneration. Neurodegeneration at both nigral as well as non-nigral regions of the brain is considered responsible for disease progression in PD. The key factors that initiate n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ae22456c475d70f00af1b4c3ec90670
https://doi.org/10.1016/j.neuint.2022.105380
https://doi.org/10.1016/j.neuint.2022.105380
Autor:
Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, Kusuma Kumari Garikapati, Sai Kiran S.S. Pindiprolu, V.V.V. Ravi Kiran Ammu
Publikováno v:
Nanotechnology in the Life Sciences ISBN: 9783030762629
Breast cancer is one of the principal causes of cancer deaths across the world. Chemoresistance, bioavailability issues and off-target effects are the significant limitations of conventional therapeutic agents in treating breast cancer. In recent yea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfc1b0dde7b27b18abf96b00fb55b61f
https://doi.org/10.1007/978-3-030-76263-6_7
https://doi.org/10.1007/978-3-030-76263-6_7
Autor:
Kusuma Kumari Garikapati, Sai Kiran S.S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, V.V.V. Ravi Kiran Ammu
Publikováno v:
Medical Hypotheses. 124:98-100
Non-Small Cell lung cancer (NSCLC) accounts for 85% of total lung cancers worldwide, affecting more than 1.5 million people every year. Recent studies reported that lung adenocarcinoma express Peroxisome Proliferator Activated Receptor-γ (PPAR-γ) w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0701e941f4ecfa8d348192b54090efd1
https://doi.org/10.1016/j.mehy.2019.02.024
https://doi.org/10.1016/j.mehy.2019.02.024
Autor:
Pavan Kumar Chintamaneni, V.V.V. Ravi Kiran Ammu, Kusuma Kumari Garikapati, Sai Kiran S.S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy
Publikováno v:
Archives of gynecology and obstetrics. 300(2)
Type-II endometrial cancer is an estrogen independent and one of the most lethal types of cancer having poor prognosis. Adipokines play a crucial role in the triggering Type-II EMC. In addition, adipokines modulators, therefore, may have beneficial e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::861571e72257c9abb350ea07f71f9e6e
https://pubmed.ncbi.nlm.nih.gov/31062150
https://pubmed.ncbi.nlm.nih.gov/31062150
Autor:
V.V.V. Ravi Kiran Ammu, Kusuma Kumari Garikapati, Pavan Kumar Chintamaneni, Sai Kiran S.S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy
Publikováno v:
Medical hypotheses. 126
Type-II Endometrial Cancer (EMC) is one of the most common types of gynaecological cancer affecting more than 2.7 million people worldwide. Clinical evidence shows that adipokines levels are abnormally altered in Type-II EMC and reported to be one of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f877885608d3dccef03c85fba60480
https://pubmed.ncbi.nlm.nih.gov/31010504
https://pubmed.ncbi.nlm.nih.gov/31010504